☰

Luigino Calzetta - Publications

Affiliations: 
2008-2012 King's College London, London, UK 
Tree Info Similar researchers PubMed Report error

180 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cazzola M, Rogliani P, Ora J, Calzetta L, Lauro D, Matera MG. Hyperglycaemia and Chronic Obstructive Pulmonary Disease. Diagnostics (Basel, Switzerland). 13. PMID 37958258 DOI: 10.3390/diagnostics13213362  0.312
2023 Calzetta L, Page C, Matera MG, Cazzola M, Rogliani P. Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders. British Journal of Pharmacology. PMID 37859567 DOI: 10.1111/bph.16272  0.547
2023 Cazzola M, Page C, Calzetta L, Singh D, Rogliani P, Matera MG. What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials. Immunotherapy. PMID 37779474 DOI: 10.2217/imt-2023-0136  0.532
2023 Rogliani P, Radovanovic D, Ora J, Starc N, Verri S, Pistocchini E, Calzetta L. Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol. Pulmonary Pharmacology & Therapeutics. 82: 102231. PMID 37414133 DOI: 10.1016/j.pupt.2023.102231  0.307
2023 Matera MG, Rinaldi B, Belardo C, Calzetta L, Cazzola M. Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthma. Expert Opinion On Drug Metabolism & Toxicology. 1-11. PMID 37376964 DOI: 10.1080/17425255.2023.2230130  0.301
2023 Laitano R, Calzetta L, Cavalli F, Cazzola M, Rogliani P. Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD. Expert Opinion On Drug Delivery. 1-14. PMID 37342873 DOI: 10.1080/17425247.2023.2228681  0.336
2023 Cazzola M, Calzetta L, Rinaldi B, De Novellis V, Rogliani P, Matera MG. Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert Review of Respiratory Medicine. 16: 1205-1212. PMID 36629483 DOI: 10.1080/17476348.2023.2167715  0.307
2022 Rogliani P, Ora J, Cavalli F, Cazzola M, Calzetta L. Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score. Journal of Clinical Medicine. 11. PMID 35956108 DOI: 10.3390/jcm11154491  0.319
2022 Calzetta L, Pistocchini E, Ritondo BL, Cavalli F, Camardelli F, Rogliani P. Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models. Heliyon. 8: e09760. PMID 35785239 DOI: 10.1016/j.heliyon.2022.e09760  0.317
2022 Cazzola M, Ora J, Calzetta L, Rogliani P, Matera MG. Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? Expert Opinion On Pharmacotherapy. 23: 917-927. PMID 35575510 DOI: 10.1080/14656566.2022.2076592  0.325
2022 Cazzola M, Page C, Rogliani P, Calzetta L, Matera MG. Dual bronchodilation for the treatment of COPD: From bench to bedside. British Journal of Clinical Pharmacology. PMID 35514240 DOI: 10.1111/bcp.15390  0.549
2022 Calzetta L, Ritondo BL, Zappa MC, Manzetti GM, Perduno A, Shute J, Rogliani P. The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. European Respiratory Review : An Official Journal of the European Respiratory Society. 31. PMID 35508331 DOI: 10.1183/16000617.0196-2021  0.353
2022 Rogliani P, Page C, Calzetta L. Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options. Expert Opinion On Pharmacotherapy. 1-4. PMID 35239465 DOI: 10.1080/14656566.2022.2047646  0.429
2021 Rogliani P, Ritondo BL, Puxeddu E, Cazzola M, Calzetta L. Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review. Respiratory Medicine. 189: 106639. PMID 34628125 DOI: 10.1016/j.rmed.2021.106639  0.366
2021 Calzetta L, Pietroiusti A, Page C, Bussolati O, Chetta A, Facciolo F, Rogliani P. Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine. Expert Review of Respiratory Medicine. PMID 34498989 DOI: 10.1080/17476348.2021.1979395  0.397
2021 Calzetta L, Aiello M, Frizzelli A, Bertorelli G, Rogliani P, Chetta A. Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence. International Journal of Molecular Sciences. 22. PMID 34281184 DOI: 10.3390/ijms22137132  0.32
2021 Cazzola M, Calzetta L, Matera MG. Long-acting muscarinic antagonists and small airways in asthma: which link? Allergy. PMID 33559139 DOI: 10.1111/all.14766  0.306
2021 Calzetta L, Aiello M, Frizzelli A, Bertorelli G, Chetta A. Small airways in asthma: from bench-to-bedside. Minerva Medica. PMID 33496163 DOI: 10.23736/S0026-4806.21.07268-2  0.312
2020 Calzetta L, Matera MG, Coppola A, Rogliani P. Prospects for severe asthma treatment. Current Opinion in Pharmacology. 56: 52-60. PMID 33310456 DOI: 10.1016/j.coph.2020.10.021  0.301
2020 Ritondo BL, Puxeddu E, Calzetta L, Cazzola M, Rogliani P. Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review. Expert Opinion On Pharmacotherapy. 1-10. PMID 33131340 DOI: 10.1080/14656566.2020.1845314  0.34
2020 Cazzola M, Page C, Rogliani P, Calzetta L, Matera MG. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent. Drugs. PMID 33025535 DOI: 10.1007/s40265-020-01412-x  0.535
2020 Rogliani P, Ritondo BL, Puxeddu E, Pane G, Cazzola M, Calzetta L. Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review. Journal of Experimental Pharmacology. 12: 233-254. PMID 32982485 DOI: 10.2147/JEP.S237480  0.324
2020 Ora J, Calzetta L, Matera MG, Cazzola M, Rogliani P. Advances with glucocorticoids in the treatment of asthma: state of the art. Expert Opinion On Pharmacotherapy. 1-12. PMID 32808828 DOI: 10.1080/14656566.2020.1807514  0.407
2020 Rogliani P, Ritondo BL, Ora J, Cazzola M, Calzetta L. SMART and as-needed therapies in mild to severe asthma: a network meta-analysis. The European Respiratory Journal. PMID 32430423 DOI: 10.1183/13993003.00625-2020  0.425
2020 Calzetta L, Ritondo BL, Matera MG, Pezzuto G, Cazzola M, Rogliani P. Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD). Expert Opinion On Investigational Drugs. 1-16. PMID 32401655 DOI: 10.1080/13543784.2020.1769064  0.399
2020 Rogliani P, Ritondo BL, Zerillo B, Cazzola M, Matera MG, Calzetta L. Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination. Copd. 1-9. PMID 32252547 DOI: 10.1080/15412555.2020.1749252  0.309
2020 Calzetta L, Ritondo BL, Matera MG, Cazzola M, Rogliani P. Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert Review of Respiratory Medicine. PMID 32168461 DOI: 10.1080/17476348.2020.1743180  0.394
2020 Matera MG, Rogliani P, Calzetta L, Cazzola M. TSLP Inhibitors for Asthma: Current Status and Future Prospects. Drugs. PMID 32078149 DOI: 10.1007/S40265-020-01273-4  0.409
2020 Matera MG, Page CP, Calzetta L, Rogliani P, Cazzola M. Pharmacology and Therapeutics of Bronchodilators Revisited. Pharmacological Reviews. 72: 218-252. PMID 31848208 DOI: 10.1124/Pr.119.018150  0.443
2019 Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola M. Severe Asthma and Biological Therapy: When, Which, and for Whom. Pulmonary Therapy. PMID 32048241 DOI: 10.1007/s41030-019-00109-1  0.311
2019 Calzetta L, Matera MG, Goldstein MF, Fairweather WR, Howard WW, Cazzola M, Rogliani P. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study. Pulmonary Pharmacology & Therapeutics. 60: 101883. PMID 31884206 DOI: 10.1016/J.Pupt.2019.101883  0.408
2019 Rogliani P, Matera MG, Facciolo F, Page C, Cazzola M, Calzetta L. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo. British Journal of Pharmacology. PMID 31660611 DOI: 10.1111/Bph.14909  0.597
2019 Calzetta L, Matera MG, Cazzola M, Rogliani P. Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients. Advances in Therapy. PMID 31654332 DOI: 10.1007/S12325-019-01119-W  0.49
2019 Calzetta L, Di Marco F, Blasi F, Cazzola M, Centanni S, Micheletto C, Rossi A, Rogliani P. Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis. Pulmonary Pharmacology & Therapeutics. 59: 101855. PMID 31639476 DOI: 10.1016/J.Pupt.2019.101855  0.423
2019 Calzetta L, Pistocchini E, Ritondo BL, Roncada P, Cito G, Britti D, Matera MG. Isolated airways in equine respiratory pharmacology: They never lie. Pulmonary Pharmacology & Therapeutics. 59: 101849. PMID 31553927 DOI: 10.1016/J.Pupt.2019.101849  0.364
2019 Rogliani P, Matera MG, Ritondo BL, De Guido I, Puxeddu E, Cazzola M, Calzetta L. Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations. Pulmonary Pharmacology & Therapeutics. 101841. PMID 31520718 DOI: 10.1016/J.Pupt.2019.101841  0.406
2019 Cazzola M, Calzetta L, Rogliani P, Matera MG. Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opinion On Investigational Drugs. 1-7. PMID 31474120 DOI: 10.1080/13543784.2019.1661990  0.448
2019 Rogliani P, Calzetta L, Ora J, Cazzola M, Matera MG. Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis. Multidisciplinary Respiratory Medicine. 14: 25. PMID 31388422 DOI: 10.1183/13993003.Congress-2019.Pa4257  0.402
2019 Matera MG, Rinaldi B, Calzetta L, Rogliani P, Cazzola M. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment. Pulmonary Pharmacology & Therapeutics. 58: 101828. PMID 31349002 DOI: 10.1016/J.Pupt.2019.101828  0.348
2019 Rogliani P, Matera MG, Calzetta L, Hanania NA, Page C, Rossi I, Andreadi A, Galli A, Coppola A, Cazzola M, Lauro D. Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients. Respiratory Medicine. 154: 86-92. PMID 31228775 DOI: 10.1016/J.Rmed.2019.06.015  0.488
2019 Cazzola M, Calzetta L, Page C, Rogliani P, Matera MG. Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics. Trends in Pharmacological Sciences. PMID 31147200 DOI: 10.1016/J.Tips.2019.04.015  0.494
2019 Matera MG, Calzetta L, Rogliani P, Cazzola M. Monoclonal antibodies for severe asthma: Pharmacokinetic profiles. Respiratory Medicine. 153: 3-13. PMID 31136930 DOI: 10.1016/J.Rmed.2019.05.005  0.318
2019 Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research. 20: 104. PMID 31133026 DOI: 10.1186/S12931-019-1078-Y  0.541
2019 Calzetta L, Crupi R, Roncada P, Pistocchini E, di Cave D, Rossi I, Cito G, Jacobson GA, Britti D. Clinical efficacy of bronchodilators in equine asthma: looking for minimal important difference. Equine Veterinary Journal. PMID 31132169 DOI: 10.1111/Evj.13137  0.407
2019 Calzetta L, Matera MG, Rogliani P. Monoclonal antibodies in severe asthma: is it worth it? Expert Opinion On Drug Metabolism & Toxicology. 15: 517-520. PMID 31104515 DOI: 10.1080/17425255.2019.1621837  0.393
2019 Cazzola M, Rogliani P, Calzetta L, Matera MG. Bronchodilators in subjects with asthma-related comorbidities. Respiratory Medicine. 151: 43-48. PMID 31047116 DOI: 10.1016/J.Rmed.2019.04.001  0.386
2019 Rogliani P, Cazzola M, Calzetta L. Cardiovascular Disease in Chronic Respiratory Disorders and Beyond. Journal of the American College of Cardiology. 73: 2178-2180. PMID 31047005 DOI: 10.1016/J.Jacc.2018.11.068  0.311
2019 Villalta D, Milanese M, Re MD, Sabatino G, Sforza M, Calzetta L, Liccardi G. Frequency of allergic sensitization to Can f 5 in North East Italy. An analysis of 1403 ISACs 112 (Component Resolved Diagnosis) collected retrospectively. European Annals of Allergy and Clinical Immunology. 51: 186-189. PMID 30983305 DOI: 10.23822/Eurannaci.1764-1489.89  0.301
2019 Calzetta L, Rogliani P, Page C, Rinaldi B, Cazzola M, Matera MG. Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways. Pulmonary Pharmacology & Therapeutics. PMID 30876907 DOI: 10.1016/J.Pupt.2019.03.004  0.586
2019 Rogliani P, Calzetta L, Matera MG, di Daniele N, Girolami A, Cazzola M, Ora J. Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease. Expert Opinion On Pharmacotherapy. 20: 737-750. PMID 30707637 DOI: 10.1080/14656566.2019.1570133  0.415
2019 Calzetta L, Cazzola M, Matera MG, Rogliani P. Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD. Chest. 155: 758-770. PMID 30660781 DOI: 10.1016/J.Chest.2018.12.016  0.345
2019 Cazzola M, Page C, Calzetta L, Matera MG. Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease. Pharmaceutical Patent Analyst. PMID 30657422 DOI: 10.4155/Ppa-2018-0030  0.599
2019 Ora J, Calzetta L, Garzillo L, Matera MG, Cazzola M, Rogliani P. Once- vs. twice-daily inhaled therapy in asthma: a network meta-analysis European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa4244  0.402
2019 Calzetta L, Matera MG, Ora J, Facciolo F, Cazzola M, Rogliani P. Mechanisms leading to the bronchorelaxant synergy of ICS/LABA/LAMA combination European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa3873  0.437
2019 Cazzola M, Calzetta L, Rogliani P, Puxeddu E, Matera MG. A long-term (2 years) efficacy and safety study of doxofylline in the treatment of asthma European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa2533  0.405
2018 Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F. LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease. 13: 3115-3130. PMID 30323582 DOI: 10.2147/Copd.S170606  0.368
2018 Cazzola M, Rogliani P, Calzetta L, Matera MG. Triple therapy single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis. The European Respiratory Journal. 52. PMID 30309975 DOI: 10.1183/13993003.01586-2018  0.328
2018 Liccardi G, Calzetta L, Milanese M, Scaglione M, Rogliani P. Occupational exposure to furry animals and asthma: The complex interconnection between work and everyday life. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 121: 512-513. PMID 30290895 DOI: 10.1016/J.Anai.2018.07.039  0.316
2018 Calzetta L, Hanania NA, Dini FL, Goldstein MF, Fairweather WR, Howard WW, Cazzola M. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomised studies (DOROTHEO 1 and DOROTHEO 2). Pulmonary Pharmacology & Therapeutics. PMID 30219705 DOI: 10.1016/J.Pupt.2018.09.007  0.399
2018 Calzetta L, Matera MG, Rogliani P, Cazzola M. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine. 12: 693-708. PMID 29972340 DOI: 10.1080/17476348.2018.1495562  0.394
2018 Cazzola M, Matera MG, Rogliani P, Calzetta L. Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? Expert Opinion On Investigational Drugs. 27: 573-581. PMID 29972333 DOI: 10.1080/13543784.2018.1492548  0.369
2018 Matera MG, Calzetta L, Gritti G, Gallo L, Perfetto B, Donnarumma G, Cazzola M, Rogliani P, Donniacuo M, Rinaldi B. Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells. European Journal of Pharmacology. 832: 114-119. PMID 29782855 DOI: 10.1016/J.Ejphar.2018.05.023  0.33
2018 Liccardi G, Calzetta L, Milanese M, Salzillo A, Manzi F, Ferrari M, Rogliani P. Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link? Copd. 15: 310-311. PMID 29733688 DOI: 10.1080/15412555.2018.1459533  0.383
2018 Cazzola M, Calzetta L, Barnes PJ, Criner GJ, Martinez FJ, Papi A, Gabriella Matera M. Efficacy and safety profile of xanthines in COPD: a network meta-analysis. European Respiratory Review : An Official Journal of the European Respiratory Society. 27. PMID 29720510 DOI: 10.1183/16000617.0010-2018  0.344
2018 Rogliani P, Ora J, Matera MG, Cazzola M, Calzetta L. The safety of dual bronchodilation on cardiovascular serious adverse events in COPD. Expert Opinion On Drug Safety. 17: 589-596. PMID 29716427 DOI: 10.1080/14740338.2018.1472232  0.399
2018 Cazzola M, Calzetta L, Rogliani P, Page C, Matera MG. Impact of doxofylline in COPD: A pair-wise meta-analysis. Pulmonary Pharmacology & Therapeutics. PMID 29705620 DOI: 10.1016/J.Pupt.2018.04.010  0.572
2018 Calzetta L, Matera MG, Facciolo F, Cazzola M, Rogliani P. Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. Respiratory Research. 19: 65. PMID 29650006 DOI: 10.1186/S12931-018-0770-7  0.367
2018 Calzetta L, Rogliani P, Facciolo F, Rinaldi B, Cazzola M, Matera MG. N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 103: 1-8. PMID 29635121 DOI: 10.1016/J.Biopha.2018.04.011  0.4
2018 Calzetta L, Matera MG, Cazzola M. Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy. Current Opinion in Pharmacology. 40: 95-103. PMID 29626716 DOI: 10.1016/J.Coph.2018.03.011  0.413
2018 Rogliani P, Matera MG, Puxeddu E, Mantero M, Blasi F, Cazzola M, Calzetta L. Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis. Pulmonary Pharmacology & Therapeutics. 50: 28-37. PMID 29609004 DOI: 10.1016/J.Pupt.2018.03.004  0.373
2018 Rogliani P, Calzetta L, Cazzola M. Is ICS-LAMA an alternative option to treat patients with COPD? The Lancet. Respiratory Medicine. 6: 316-317. PMID 29605621 DOI: 10.1016/S2213-2600(18)30139-5  0.329
2018 Calzetta L, Rogliani P, Pistocchini E, Mattei M, Cito G, Alfonsi P, Page C, Matera MG. Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways. Journal of Veterinary Pharmacology and Therapeutics. 41: 546-554. PMID 29582435 DOI: 10.1111/Jvp.12504  0.54
2018 Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani P. How does race/ethnicity influence pharmacological response to asthma therapies? Expert Opinion On Drug Metabolism & Toxicology. 14: 435-446. PMID 29528249 DOI: 10.1080/17425255.2018.1449833  0.364
2018 Matera MG, Calzetta L, Puxeddu E, Rogliani P, Cazzola M. A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion On Drug Safety. 17: 509-517. PMID 29505318 DOI: 10.1080/14740338.2018.1448786  0.351
2018 Shute JK, Puxeddu E, Calzetta L. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD. Current Opinion in Pharmacology. 40: 39-45. PMID 29455115 DOI: 10.1016/J.Coph.2018.01.006  0.467
2018 Calzetta L, Matera MG, Rogliani P, Cazzola M. Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how. Expert Review of Respiratory Medicine. 12: 261-264. PMID 29451042 DOI: 10.1080/17476348.2018.1442216  0.38
2018 Calzetta L, Rogliani P, Pistocchini E, Mattei M, Cito G, Alfonsi P, Page C, Matera MG. Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue. Pulmonary Pharmacology & Therapeutics. 49: 88-94. PMID 29408044 DOI: 10.1016/J.Pupt.2018.01.010  0.502
2018 Calzetta L, Rogliani P, Page C, Roncada P, Pistocchini E, Soggiu A, Piras C, Urbani A, Matera MG. Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis. Equine Veterinary Journal. 50: 594-601. PMID 29393535 DOI: 10.1111/Evj.12815  0.54
2018 Liccardi G, Calzetta L, Milanese M, Lombardi C, Savi E, Passalacqua G, Rogliani P. Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? Human Vaccines & Immunotherapeutics. 14: 1438-1441. PMID 29381449 DOI: 10.1080/21645515.2018.1434383  0.333
2018 Jacobson GA, Raidal S, Hostrup M, Calzetta L, Wood-Baker R, Farber MO, Page CP, Walters EH. Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed. Drug Safety. PMID 29332144 DOI: 10.1007/S40264-017-0631-1  0.558
2018 Rogliani P, Ora J, Puxeddu E, Calzetta L, Cavalli F, Matera MG, Cazzola M. Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study. Pulmonary Pharmacology & Therapeutics. 49: 20-26. PMID 29294360 DOI: 10.1016/J.Pupt.2017.12.010  0.393
2018 Matera MG, Rogliani P, Calzetta L, Cazzola M. Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma. Expert Opinion On Drug Metabolism & Toxicology. 14: 239-245. PMID 29268638 DOI: 10.1080/17425255.2018.1421170  0.345
2018 Cazzola M, Calzetta L, Page C, Rogliani P, Matera MG. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. Pulmonary Pharmacology & Therapeutics. 48: 185-194. PMID 29233650 DOI: 10.1016/J.Pupt.2017.11.009  0.583
2018 Shute JK, Calzetta L, Cardaci V, di Toro S, Page CP, Cazzola M. Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study. Pulmonary Pharmacology & Therapeutics. 48: 88-96. PMID 28986203 DOI: 10.1016/J.Pupt.2017.10.001  0.585
2017 Matera MG, Rogliani P, Calzetta L, Canonica GW, Cazzola M. Benralizumab for the treatment of asthma. Drugs of Today (Barcelona, Spain : 1998). 53: 633-645. PMID 29517082 DOI: 10.1358/Dot.2017.53.12.2736670  0.371
2017 Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L. The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis. International Journal of Chronic Obstructive Pulmonary Disease. 12: 3469-3485. PMID 29255354 DOI: 10.2147/Copd.S146338  0.335
2017 Matera MG, Rinaldi B, Calzetta L, Cazzola M. Pharmacogenetic and pharmacogenomic considerations of asthma treatment. Expert Opinion On Drug Metabolism & Toxicology. 13: 1159-1167. PMID 28992739 DOI: 10.1080/17425255.2017.1391215  0.392
2017 Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG. Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. Trends in Pharmacological Sciences. 38: 940-951. PMID 28784329 DOI: 10.1016/J.Tips.2017.07.003  0.513
2017 Cazzola M, Rogliani P, Calzetta L, Hanania NA, Matera MG. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. Copd. 14: 552-563. PMID 28753070 DOI: 10.1080/15412555.2017.1347918  0.42
2017 Calzetta L, Rogliani P, Mattei M, Alfonsi P, Cito G, Pistocchini E, Cazzola M, Matera MG. Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi. Copd. 14: 526-532. PMID 28745522 DOI: 10.1080/15412555.2017.1344627  0.419
2017 Matera MG, Calzetta L, Rinaldi B, Cazzola M. Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. Expert Opinion On Drug Metabolism & Toxicology. 13: 1007-1013. PMID 28737051 DOI: 10.1080/17425255.2017.1359253  0.318
2017 Calzetta L, Ora J, Cavalli F, Rogliani P, O'Donnell DE, Cazzola M. Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. Respiratory Medicine. 129: 189-198. PMID 28732830 DOI: 10.1016/J.Rmed.2017.06.020  0.319
2017 Calzetta L, Rogliani P, Facciolo F, Rendina E, Cazzola M, Matera MG. Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi. European Journal of Pharmacology. 812: 147-154. PMID 28716723 DOI: 10.1016/J.Ejphar.2017.07.026  0.378
2017 Calzetta L, Matera MG, Braido F, Contoli M, Corsico A, Di Marco F, Santus P, Scichilone N, Cazzola M, Rogliani P. Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. Pulmonary Pharmacology & Therapeutics. 45: 148-158. PMID 28606478 DOI: 10.1016/J.Pupt.2017.06.002  0.411
2017 Calzetta L, Puxeddu E, Rogliani P. Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine. Ebiomedicine. 19: 14-15. PMID 28473238 DOI: 10.1016/J.Ebiom.2017.04.035  0.355
2017 Cazzola M, Calzetta L, Rinaldi B, Page C, Rosano G, Rogliani P, Matera MG. Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases. Drugs. 77: 721-732. PMID 28349353 DOI: 10.1007/S40265-017-0731-3  0.581
2017 Rogliani P, Calzetta L, Coppola A, Cavalli F, Ora J, Puxeddu E, Matera MG, Cazzola M. Optimizing drug delivery in COPD: The role of inhaler devices. Respiratory Medicine. 124: 6-14. PMID 28284323 DOI: 10.1016/J.Rmed.2017.01.006  0.322
2017 Liccardi G, Calzetta L, Barrile A, Giorgino FM, Sapio C, Rogliani P. Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? Journal of Occupational Health. 59: 310-311. PMID 28260737 DOI: 10.1539/Joh.17-0025-Lte  0.353
2017 Cazzola M, Calzetta L, Rogliani P, Matera MG. The Challenges of Precision Medicine in COPD. Molecular Diagnosis & Therapy. 21: 345-355. PMID 28247183 DOI: 10.1007/S40291-017-0266-Z  0.391
2017 Cazzola M, Calzetta L, Rogliani P, Matera MG. Tiotropium formulations and safety: a network meta-analysis. Therapeutic Advances in Drug Safety. 8: 17-30. PMID 28203364 DOI: 10.1177/2042098616667304  0.319
2017 Cazzola M, Calzetta L, Facciolo F, Rogliani P, Matera MG. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation. Respiratory Research. 18: 26. PMID 28118826 DOI: 10.1186/S12931-016-0500-Y  0.302
2017 Calzetta L, Rogliani P, Ora J, Puxeddu E, Cazzola M, Matera MG. LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. European Respiratory Review : An Official Journal of the European Respiratory Society. 26. PMID 28096283 DOI: 10.1183/16000617.0043-2016  0.39
2017 Matera MG, Rinaldi B, Calzetta L, Cazzola M. Assessing the viability of long-acting β-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective. Expert Opinion On Drug Metabolism & Toxicology. 13: 129-136. PMID 27615145 DOI: 10.1080/17425255.2017.1234604  0.3
2017 Cazzola M, Calzetta L, Ora J, Cavalli F, O'Donnell DE, Rogliani P. LABA/LAMA combination, exercise and lung hyperinflation in COPD: a meta-analysis European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa683  0.362
2017 Rogliani P, Calzetta L, Ora J, Puxeddu E, Cazzola M, Matera MG. Clinical synergism of LABA/LAMA combinations in COPD patients European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa1814  0.413
2017 Calzetta L, Rogliani P, Facciolo F, Rinaldi B, Matera MG, Cazzola M. N-Acetylcysteine protects human bronchi via inhibiting neurokinin A European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa1807  0.34
2017 Calzetta L, Rogliani P, Facciolo F, Matera MG, Cazzola M. Interaction between tiotropium bromide and olodaterol in small human airways European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa1055  0.403
2017 Rogliani P, Calzetta L, Ora J, Cazzola M, Lauro D, Matera MG, Coppola A. Effect of exendin-4 on lung function of diabetic patients: a preliminary report European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa1039  0.341
2017 Calzetta L, Rogliani P, Cavalli F, Puxeddu E, Facciolo F, Cazzola M, Matera MG. Protein tyrosin kinase and KCa++ cannel: two faces of the same coin in LABA/LAMA synergy European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Oa4407  0.323
2017 Calzetta L, Roncada P, di Cave D, Bonizzi L, Urbani A, Pistocchini E, Rogliani P, Matera MG. Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis Equine Veterinary Journal. 49: 710-717. DOI: 10.1111/Evj.12680  0.458
2016 Rogliani P, Puxeddu E, Ciaprini C, Ora J, Onorato A, Pezzuto G, Calzetta L, Cazzola M. The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils. Biomed Research International. 2016: 4547953. PMID 27822474 DOI: 10.1155/2016/4547953  0.336
2016 Soggiu A, Piras C, Greco V, Devoto P, Urbani A, Calzetta L, Bortolato M, Roncada P. Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens. Psychoneuroendocrinology. 74: 387-396. PMID 27750143 DOI: 10.1016/J.Psyneuen.2016.10.001  0.303
2016 Lauretti S, Cardaci V, Barrese F, Calzetta L. Chronic obstructive pulmonary disease (COPD) and erectile dysfunction (ED): Results of the BRED observational study. Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica. 88: 165-170. PMID 27711087 DOI: 10.4081/Aiua.2016.3.165  0.376
2016 Liccardi G, Salzillo A, Calzetta L, Ora J, Rogliani P. Gastroesophageal reflux and COPD exacerbations: Is cholinergic-mediated oesophago-bronchial reflex a possible link? Respirology (Carlton, Vic.). 21: 1496-1497. PMID 27634491 DOI: 10.1111/Resp.12896  0.409
2016 Matera MG, Page C, Rogliani P, Calzetta L, Cazzola M. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease. Drugs. 76: 1257-70. PMID 27506851 DOI: 10.1007/S40265-016-0625-9  0.565
2016 Liccardi G, Salzillo A, Calzetta L, Cazzola M, Matera MG, Rogliani P. Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics. Respiratory Medicine. 117: 150-3. PMID 27492525 DOI: 10.1016/J.Rmed.2016.05.026  0.397
2016 Rogliani P, Calzetta L, Cavalli F, Matera MG, Cazzola M. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Pulmonary Pharmacology & Therapeutics. PMID 27481628 DOI: 10.1016/J.Pupt.2016.07.009  0.351
2016 Calzetta L, Orlandi A, Page C, Rogliani P, Rinaldi B, Rosano G, Cazzola M, Matera MG. Brain natriuretic peptide: Much more than a biomarker. International Journal of Cardiology. 221: 1031-1038. PMID 27447810 DOI: 10.1016/J.Ijcard.2016.07.109  0.535
2016 Liccardi G, Salzillo A, Piccolo A, Calzetta L, Rogliani P. Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens. Upsala Journal of Medical Sciences. 121: 196-7. PMID 27399169 DOI: 10.3109/03009734.2016.1173745  0.386
2016 Liccardi G, Salzillo A, Calzetta L, Ora J, Cazzola M, Matera MG, Rogliani P. Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? The Journal of Allergy and Clinical Immunology. in Practice. 4: 791-3. PMID 27393788 DOI: 10.1016/J.Jaip.2016.03.025  0.367
2016 Cazzola M, Ora J, Di Paolo A, Puxeddu E, Calzetta L, Rogliani P. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD. Pulmonary Pharmacology & Therapeutics. 39: 48-53. PMID 27344046 DOI: 10.1016/J.Pupt.2016.06.006  0.46
2016 Cazzola M, Calzetta L, Puxeddu E, Ora J, Facciolo F, Rogliani P, Matera MG. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respiratory Research. 17: 70. PMID 27296533 DOI: 10.1186/S12931-016-0386-8  0.324
2016 Rogliani P, Calzetta L, Cazzola M, Matera MG. Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. Expert Opinion On Drug Safety. 15: 1133-46. PMID 27279341 DOI: 10.1080/14740338.2016.1199683  0.387
2016 Calzetta L, Rinaldi B, Cazzola M, Matera MG. Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma. Expert Opinion On Drug Metabolism & Toxicology. 12: 813-22. PMID 27253498 DOI: 10.1080/17425255.2016.1192125  0.391
2016 Cazzola M, Calzetta L, Rogliani P, Matera MG. The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Opinion On Drug Discovery. 11: 733-44. PMID 27169612 DOI: 10.1080/17460441.2016.1184642  0.423
2016 Liccardi G, Salzillo A, Calzetta L, Piccolo A, Rogliani P. Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? The Journal of Allergy and Clinical Immunology. 137: 1621-2. PMID 26971691 DOI: 10.1016/J.Jaci.2015.12.1328  0.316
2016 Matera MG, Rogliani P, Calzetta L, Cazzola M. Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update. Drug Safety. 39: 501-8. PMID 26924197 DOI: 10.1007/S40264-016-0402-4  0.413
2016 Calzetta L, Rogliani P, Matera MG, Cazzola M. A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. Chest. 149: 1181-96. PMID 26923629 DOI: 10.1016/J.Chest.2016.02.646  0.353
2016 Calzetta L, Ciaprini C, Puxeddu E, Cazzola M. Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine. 10: 379-386. PMID 26894830 DOI: 10.1586/17476348.2016.1156538  0.399
2016 Cazzola M, Calzetta L, Rogliani P, Puxeddu E, Facciolo F, Matera MG. Interaction between corticosteroids and muscarinic antagonists in human airways. Pulmonary Pharmacology & Therapeutics. 36: 1-9. PMID 26656790 DOI: 10.1016/J.Pupt.2015.11.004  0.419
2016 Matera MG, Calzetta L, Cazzola M. Oxidation pathway and exacerbations in COPD: the role of NAC. Expert Review of Respiratory Medicine. 10: 89-97. PMID 26567752 DOI: 10.1586/17476348.2016.1121105  0.402
2016 Rogliani P, Ora J, Calzetta L, Lucà G, Matera MG, Cazzola M. Pharmacological characterization of the anti-oxidant activity of N-acetylcysteine in anex vivomodel of COPD exacerbation European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa5062  0.349
2016 Calzetta L, Rogliani P, Puxeddu E, Ora J, Facciolo F, Matera MG, Cazzola M. Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa5057  0.335
2016 Calzetta L, Rogliani P, Lucà G, Matera MG, Cazzola M. Anti-inflammatory profile of N-acetylcysteine in human bronchi stimulated with lipopolysaccharide European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa4096  0.392
2016 Calzetta L, Rogliani P, Puxeddu E, Ora J, Facciolo F, Matera MG, Cazzola M. Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa4090  0.364
2016 Rogliani P, Puxeddu E, Ciaprini C, Pezzuto G, Calzetta L, Cazzola M. The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa3663  0.348
2016 Shute J, Calzetta L, Cardaci V, Toro SD, Page C, Cazzola M. A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Oa3311  0.544
2015 Calzetta L, Soggiu A, Roncada P, Bonizzi L, Pistocchini E, Urbani A, Rinaldi B, Matera MG. Propofol protects against opioid-induced hyperresponsiveness of airway smooth muscle in a horse model of target-controlled infusion anaesthesia. European Journal of Pharmacology. 765: 463-71. PMID 26368667 DOI: 10.1016/J.Ejphar.2015.09.007  0.349
2015 Cazzola M, Calzetta L, Page C, Jardim J, Chuchalin AG, Rogliani P, Matera MG. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. European Respiratory Review : An Official Journal of the European Respiratory Society. 24: 451-61. PMID 26324807 DOI: 10.1183/16000617.00002215  0.556
2015 Cazzola M, Calzetta L, Ora J, Puxeddu E, Rogliani P, Matera MG. Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside. Respiratory Medicine. 109: 1305-11. PMID 26303336 DOI: 10.1016/J.Rmed.2015.08.005  0.389
2015 Cazzola M, Calzetta L, Matera MG, Muscoli S, Rogliani P, Romeo F. Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. Respiratory Medicine. PMID 26111914 DOI: 10.1016/J.Rmed.2015.05.021  0.341
2015 Calzetta L, Matera MG, Cazzola M. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. European Journal of Pharmacology. 761: 168-173. PMID 25981302 DOI: 10.1016/J.Ejphar.2015.05.020  0.413
2015 Rogliani P, Calzetta L, Ora J, Lipsi R, Segreti A, Matera MG, Cazzola M. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi. European Journal of Pharmacology. PMID 25952728 DOI: 10.1016/J.Ejphar.2015.04.042  0.389
2015 Calzetta L, Luongo L, Cazzola M, Page C, Rogliani P, Facciolo F, Maione S, Capuano A, Rinaldi B, Matera MG. Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. Life Sciences. 131: 44-50. PMID 25914087 DOI: 10.1016/J.Lfs.2015.03.023  0.442
2015 Calzetta L, Cazzola M, Page CP, Rogliani P, Facciolo F, Matera MG. Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. Pulmonary Pharmacology & Therapeutics. 32: 15-23. PMID 25899618 DOI: 10.1016/J.Pupt.2015.03.007  0.544
2015 Cazzola M, Calzetta L, Matera MG. Aclidinium/formoterol fixed-dose combination for the treatment of chronic obstructive pulmonary disease. Drugs of Today (Barcelona, Spain : 1998). 51: 97-105. PMID 25756065 DOI: 10.1358/Dot.2015.51.2.2273382  0.397
2015 Orlandi A, Calzetta L, Doldo E, Tarquini C, Matera MG, Passeri D. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells. Pulmonary Pharmacology & Therapeutics. 31: 51-4. PMID 25722070 DOI: 10.1016/J.Pupt.2015.02.005  0.328
2015 Rogliani P, Calzetta L, Ora J, Matera MG. Canakinumab for the treatment of chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 31: 15-27. PMID 25660162 DOI: 10.1016/J.Pupt.2015.01.005  0.374
2015 Cazzola M, Calzetta L, Segreti A, Facciolo F, Rogliani P, Matera MG. Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. Copd. 12: 175-81. PMID 25222881 DOI: 10.3109/15412555.2014.922172  0.395
2015 Calzetta L, Ora J, Rogliani P, Matera MG, Cazzola M. Searching for synergistic interaction between aclidinium (ACL) and formoterol (FOR): From bench to bedside European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa993  0.354
2015 Calzetta L, Rinaldi B, Donniacuo M, Martuscelli E, Orlandi A, Matera MG. Effects of the new ultra-long-acting β2-AR agonist indacaterol in chronic treatment alone or in combination with the β1-AR blocker metoprolol on cardiac remodelling European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa992  0.31
2015 Calzetta L, Rinaldi B, Gritti G, Donniacuo M, Donnarumma G, Matera MG. Effect of simvastatin on steroid-resistence in human epithelial cultured cells: A preliminary study European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa3572  0.331
2015 Ora J, Calzetta L, Rogliani P, Ciaprini C, Capuano R, Martinelli E, Paolesse R, Natale CD, Cazzola M. Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa2094  0.351
2015 Rogliani P, Lipsi R, Ora J, Lucà G, Calzetta L, Cazzola M. Onset of action of aclidinium (ACL), glycopyrronium (GLY) and tiotropium (TIO): A comparison in COPD patients European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1496  0.34
2014 Cazzola M, Calzetta L, Page CP, Rogliani P, Facciolo F, Gavaldà A, Matera MG. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. European Journal of Pharmacology. 745: 135-43. PMID 25446566 DOI: 10.1016/j.ejphar.2014.10.025  0.447
2014 Segreti A, Calzetta L, Rogliani P, Cazzola M. Umeclidinium for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine. 8: 665-71. PMID 25312239 DOI: 10.1586/17476348.2014.962519  0.338
2014 Matera MG, Rogliani P, Calzetta L, Cazzola M. Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? Drugs. 74: 1983-92. PMID 25300411 DOI: 10.1007/s40265-014-0303-8  0.31
2014 Calzetta L, Rogliani P, Cazzola M, Matera MG. Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond. Expert Opinion On Drug Discovery. 9: 595-607. PMID 24749518 DOI: 10.1517/17460441.2014.909403  0.318
2014 Matera MG, Calzetta L, Rogliani P, Cesario A, Cazzola M. New treatments for COPD in the elderly. Current Pharmaceutical Design. 20: 5968-82. PMID 24641227  0.325
2014 Cazzola M, Calzetta L, Page CP, Matera MG. Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation. Expert Opinion On Drug Metabolism & Toxicology. 10: 129-37. PMID 24295085 DOI: 10.1517/17425255.2014.865723  0.434
2014 Calzetta L, Passeri D, Kanabar V, Rogliani P, Page C, Cazzola M, Matera MG, Orlandi A. Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism. American Journal of Respiratory Cell and Molecular Biology. 50: 493-501. PMID 24074453 DOI: 10.1165/Rcmb.2013-0119Oc  0.476
2013 Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. The Lancet. Respiratory Medicine. 1: 714-27. PMID 24429275 DOI: 10.1016/S2213-2600(13)70187-5  0.552
2013 Calzetta L, Page CP, Spina D, Cazzola M, Rogliani P, Facciolo F, Matera MG. Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone. The Journal of Pharmacology and Experimental Therapeutics. 346: 414-23. PMID 23766543 DOI: 10.1124/jpet.113.204644  0.446
2012 Pasqua F, Alesii A, Geraneo K, Di Toro S, La Torre G, Sferrazza A, Mastrullo MG, Calzetta L, Bonassi S, Cardaci V, Cesario A. A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ). Multidisciplinary Respiratory Medicine. 7: 46. PMID 23168213 DOI: 10.1186/2049-6958-7-46  0.339
2012 Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP, Kanabar V, Matera MG. High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. American Journal of Respiratory Cell and Molecular Biology. 47: 509-16. PMID 22652200 DOI: 10.1165/rcmb.2011-0449OC  0.403
2012 Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacological Reviews. 64: 450-504. PMID 22611179 DOI: 10.1124/pr.111.004580  0.538
2012 Matera MG, Calzetta L, Rinaldi B, Cazzola M. Treatment of COPD: moving beyond the lungs. Current Opinion in Pharmacology. 12: 315-22. PMID 22552103 DOI: 10.1016/J.Coph.2012.04.001  0.418
2012 Cazzola M, Page CP, Calzetta L, Matera MG. Emerging anti-inflammatory strategies for COPD. The European Respiratory Journal. 40: 724-41. PMID 22496331 DOI: 10.1183/09031936.00213711  0.477
2012 Matera MG, Calzetta L, Segreti A, Cazzola M. Emerging drugs for chronic obstructive pulmonary disease. Expert Opinion On Emerging Drugs. 17: 61-82. PMID 22335427 DOI: 10.1517/14728214.2012.660917  0.302
2012 Hewson CA, Patel S, Calzetta L, Campwala H, Havard S, Luscombe E, Clarke PA, Peachell PT, Matera MG, Cazzola M, Page C, Abraham WM, Williams CM, Clark JD, Liu WL, et al. Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma. The Journal of Pharmacology and Experimental Therapeutics. 340: 656-65. PMID 22160268 DOI: 10.1124/Jpet.111.186379  0.506
2012 Cazzola M, Calzetta L, Bettoncelli G, Cricelli C, Romeo F, Matera MG, Rogliani P. Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study. Respiratory Medicine. 106: 249-56. PMID 21856140 DOI: 10.1016/J.Rmed.2011.07.021  0.384
2011 Calzetta L, Spina D, Cazzola M, Page CP, Facciolo F, Rendina EA, Matera MG. Pharmacological characterization of adenosine receptors on isolated human bronchi. American Journal of Respiratory Cell and Molecular Biology. 45: 1222-31. PMID 21700958 DOI: 10.1165/Rcmb.2011-0056Oc  0.528
2011 Matera MG, Calzetta L, Passeri D, Facciolo F, Rendina EA, Page C, Cazzola M, Orlandi A. Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi. British Journal of Pharmacology. 163: 1740-54. PMID 21410689 DOI: 10.1111/J.1476-5381.2011.01339.X  0.44
2011 Cazzola M, Calzetta L, Page CP, Rinaldi B, Capuano A, Matera MG. Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi. American Journal of Respiratory Cell and Molecular Biology. 45: 704-10. PMID 21278325 DOI: 10.1165/rcmb.2010-0306OC  0.414
2011 Matera MG, Calzetta L, Rogliani P, Bardaro F, Page CP, Cazzola M. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi. Pulmonary Pharmacology & Therapeutics. 24: 221-6. PMID 21195788 DOI: 10.1016/j.pupt.2010.12.008  0.513
2011 Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, Calzetta L. The prevalence of asthma and COPD in Italy: a practice-based study. Respiratory Medicine. 105: 386-91. PMID 20951017 DOI: 10.1016/J.Rmed.2010.09.022  0.311
2011 Cazzola M, Calzetta L, Matera MG. The cardiovascular risk of tiotropium: is it real? Expert Opinion On Drug Safety. 9: 783-92. PMID 20565229 DOI: 10.1517/14740338.2010.500611  0.344
2011 Cazzola M, Segreti A, Bettoncelli G, Calzetta L, Cricelli C, Pasqua F, Rogliani P. Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008 Primary Care Respiratory Journal. 20: 291-298. DOI: 10.4104/Pcrj.2011.00033  0.446
2009 Matera MG, Calzetta L, Cazzola M. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulmonary Pharmacology & Therapeutics. 23: 121-8. PMID 19853667 DOI: 10.1016/J.Pupt.2009.10.007  0.361
2008 Matera MG, Calzetta L, Sanduzzi A, Page CP, Cazzola M. Effects of neuraminidase on equine isolated bronchi. Pulmonary Pharmacology & Therapeutics. 21: 624-9. PMID 18394940 DOI: 10.1016/J.Pupt.2008.02.003  0.443
Show low-probability matches.